Effect of fentanyl on 5-HT efflux involves both opioid and 5-HT 1A receptors

British Journal of Pharmacology

Volumn 139, Issue 8, 2003, Pages 1498-1504

  Tao, Rui ^a   Karnik, Meghana ^b   Ma, Zhiyuan ^a   Auerbach, Sidney B ^b  

^a HARVARD MEDICAL SCHOOL   (United States)

^b RUTGERS UNIVERSITY   (United States)

Author keywords

5 HT 1A receptor; Dorsal raphe nucleus; Fentanyl; Microdialysis; Opioid receptor; Serotonin

Indexed keywords

ANALGESIC AGENT; BINALTORPHIMINE; FENTANYL; KAPPA OPIATE RECEPTOR; MU OPIATE RECEPTOR; N [2 [4 (2 METHOXYPHENYL) 1 PIPERAZINYL]ETHYL] N (2 PYRIDYL)CYCLOHEXANECARBOXAMIDE; NALTREXONE; OPIATE RECEPTOR; PINDOLOL; SEROTONIN; SEROTONIN 1A AGONIST; SEROTONIN 1A RECEPTOR;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DOPAMINERGIC NERVE CELL; DORSAL RAPHE NUCLEUS; DOSE RESPONSE; DRUG EFFECT; DRUG INFUSION; DRUG RECEPTOR BINDING; MALE; MICRODIALYSIS; NONHUMAN; PRIORITY JOURNAL; RAT; RECEPTOR BLOCKING; SEROTONIN RELEASE;

ANALGESICS, OPIOID; ANIMALS; DOSE-RESPONSE RELATIONSHIP, DRUG; FENTANYL; INJECTIONS, SUBCUTANEOUS; MALE; MICRODIALYSIS; NARCOTIC ANTAGONISTS; RAPHE NUCLEI; RATS; RATS, SPRAGUE-DAWLEY; RECEPTOR, SEROTONIN, 5-HT1A; RECEPTORS, OPIOID, MU;

EID: 0141763505     PISSN: 00071188     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjp.0705378     Document Type: Article

References (33)

1. A, and glutamate receptors. J. Neurosci., 21, 9917-9929.
2. CHATURVEDI, K., SHAHRESTANIFAR, M. & HOWELLS, R. (2000). μ Opioid receptor: role for the amino terminus as a determinant of ligand binding affinity. Mol. Brain Res., 76, 64-72.
3. 1A receptors in fentanyl-induced bulbospinal inhibition of a spinal withdrawal reflex in the rabbit. Pain, 85, 239-245.
4. 1A autoreceptor in vivo. Br. J. Pharmacol., 124, 206-212.
5. DYKSTRA, K.H., HSIAO, J.K., MORRISON, P.P., BUNGAY, P.M., MEFFORD, I.N., SCULLY, M.M. & DEDRICK, R.L. (1992). Quantitative examination of tissue concentration profiles associated with microdialysis. J. Neurochem., 58, 931-940.
6. ENDOH, T., MATSUURA, H., TANAKA, C. & NAGASE, H. (1992). Nor-binaltorphimine: a potent and selective κ-opioid receptor antagonist with long-lasting activity in vivo. Arch. Int. Pharmacodyn. Ther., 316, 30-42.
7. 1A receptor antagonist. Behav. Brain Res., 73, 337-353.
8. FORNAL, C.A., MARTIN, F.J., METZLER, C.W. & JACOBS, B.L. (1999). Pindolol suppresses serotonergic neuronal activity and does not block the inhibition of serotonergic neurons produced by 8-hydroxy-2-(di-n-propylamino)tetralin in awake cats. J. Pharmacol. Exp. Ther., 291, 229-238.
9. GERVASONI, D., PEYRON, C., RAMPON, C., BARBAGLI, B., CHOUVET, G., URBAIN, N., FORT, P. & LUPPI, P.H. (2000). Role and origin of the GABAergic innervation of dorsal raphe serotonergic neurons. J. Neurosci., 20, 4217-4225.
10. HUG, JR, C.C. & MURPHY, M.R. (1981). Tissue redistribution of fentanyl and termination of its effects in rats. Anesthesiology, 55, 369-375.
11. JANG, Y. & YOBURN, B.C. (1991). Evaluation of receptor mechanism mediating fentanyl analgesia and toxicity. Eur. J. Pharmacol., 197, 135-141.
12. JOLAS, T. & AGHAJANIAN, G.K. (1997). Opioids suppress spontaneous and NMDA-induced inhibitory postsynaptic currents in the dorsal raphe nucleus of the rat in vitro. Brain Res., 755, 229-245.
13. KALYUZHNY, A.E. & WESSENDORF, M.W. (1997). CNS GABA neurons express the μ-opioid receptor: immunocytochemical studies. Neuroreport, 8, 3367-3372.
14. 1A receptor-mediated modulation of medullary expiratory neurones in the cat. J. Physiol. (Lond.), 476, 117-130.
15. MAGUIRE, P., TSAI, N., KAMAL, J., COMETTA-MORINI, C., UPTON, C. & LOEW, G. (1992). Pharmacological profiles of fentanyl analogs at μ, δ and κ opiate receptors. Eur. J. Pharmacol., 213, 219-225.
16. 1A receptors in membranes from the rat brain. Neuropharmacology, 30, 323-327.
17. MEGENS, A.A., ARTOIS, K., VERMEIRE, J., MEERT, T. & AWOUTERS, F.H. (1998). Comparison of the analgesic and intestinal effects of fentanyl and morphine in rats. J. Pain Symptom Manage., 15, 253-257.
18. 3H]5-hydroxytryptamine release are not related to their antinociceptive action. Eur. J. Pharmacol., 272, 51-56.
19. PAXINOS, G. & WATSON, C. (1986). The Rat Brain in Stereotaxic Coordinates. 2nd edn. Sydney: Academic Press.
20. PINNOCK, R.D. (1992). Activation of kappa-opioid receptors depresses electrically evoked excitatory postsynaptic potentials on 5-HT-sensitive neurones in the rat dorsal raphe nucleus in vitro. Brain Res., 583, 237-246.
21. RICHTER, D.W., SCHMIDT-GARCON, P., PIERREFICHE, O., BISCHOFF, A.M. & LALLEY, P.M. (1999). Neurotransmitters and neuromodulators controlling the hypoxic respiratory response in anaesthetized cats. J. Physiol. (Lond.), 514, 567-578.
22. 1A receptors. J. Pharmacol. Exp. Ther., 292, 704-713.
23. SHARP, T., BRAMWELL, S.R., HJORTH, S. & GRAHAME-SMITH, D.G. (1989). Pharmacological characterization of 8-OH-DPAT-induced inhibition of rat hippocampal 5-HT release in vivo as measured by microdialysis. Br. J. Pharmacol., 98, 989-997.
24. SINGH, V.P., JAIN, N.K. & KULKARNI, S.K. (2001). On the antinociceptive effect of fluoxetine, a selective serotonin reuptake inhibitor. Brain Res., 915, 218-226.
25. TAO, R. & AUERBACH, S.B. (1994). Anesthetics block morphine-induced increases in serotonin release in rat CNS. Synapse, 18, 307-314.
26. TAO, R. & AUERBACH, S.B. (1995). Involvement of the dorsal raphe but not median raphe nucleus in morphine-induced increases in serotonin release in the rat forebrain. Neuroscience, 68, 553-561.
27. TAO, R. & AUERBACH, S.B. (2000). Regulation of serotonin release by GABA and excitatory amino acids. J. Psychopharmacol., 14, 100-113.
28. TAO, R. & AUERBACH, S.B. (2002a). GABAergic and glutamatergic afferents in the dorsal raphe nucleus mediate morphine-induced increases in serotonin efflux in the rat central nervous system. J. Pharmacol. Exp. Ther., 303, 704-710.
29. TAO, R. & AUERBACH, S.B. (2002b). Opioid receptor subtypes differentially modulate serotonin efflux in the rat central nervous system. J. Pharmacol. Exp. Ther., 303, 549-556.
30. TAO, R. & AUERBACH, S.B. (2003). Influence of inhibitory and excitatory inputs on serotonin differs in the dorsal and median raphe nuclei. Brain Res., 961, 109-120.
31. B receptors in midbrain raphe nuclei and forebrain of rats. Br. J. Pharmacol., 119, 1375-1384.
32. WANG, Q.P. & NAKAI, Y. (1994). The dorsal raphe: an important nucleus in pain modulation. Brain Res. Bull, 34, 575-585.
33. XU, W., CUI, X. & HAN, J.S. (1994). Spinal serotonin 1A and 1C/2 receptors mediate supraspinal mu opioid-induced anatgesia. Neuroreport, 5, 2665-2668.